Global Biopharmaceutical Company Advances Pharmaceutical Operations in Japan with LifeSphere Solutions
Deployment of LifeSphere Intake & Triage, Literature Intelligence, and Reporter enhances efficiency, ...
Webinar: Leveraging AI for Intelligent Adverse Event and Product Complaint Intake

Join peers from global pharma to explore how ReporterX is redefining safety and quality complaints intake.
Webinar: The Rise of Intelligence Agents

AI Intelligence agents that interpret regulatory change and assess real-time impact.
Deployment of LifeSphere Intake & Triage, Literature Intelligence, and Reporter enhances efficiency, ...
Based on the Life Sciences AI Exchange podcast panel discussion, the article explores why data transformation remains one of the biggest barriers to successful AI adoption in life sciences. The discussion examines the industry's ongoing challenges with fragmented data, the realities of preparing organizations for AI at scale, and the steps companies must take to create a stronger foundation for future innovation.
Collaboration combines AI technology and operational expertise to help life sciences organizations ...
Modular, system-agnostic product design enables rapid deployment on top of existing safety systems ...
Expanding NavaX adoption, new Top Pharma wins, and continued global ...
New Distribution, Signals, and Intelligence Agents reduce manual effort, streamline compliance tasks, and orchestrate end-to-end decision workflows.
New NavaX-powered capabilities combine Dynamic Data Extraction, Translation, Conversational AI, and Intelligent Follow-up Management to modernize adverse event, medical information and product quality complaints reporting.
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety ...
XDI brings the first federated solution for life sciences, collapsing data silos, unifying meaning, and ...
MADRID, SPAIN – February 11, 2026 – ArisGlobal, an AI-first technology company at ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved